BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25320005)

  • 1. Molecular characterization of chronic-type adult T-cell leukemia/lymphoma.
    Yoshida N; Karube K; Utsunomiya A; Tsukasaki K; Imaizumi Y; Taira N; Uike N; Umino A; Arita K; Suguro M; Tsuzuki S; Kinoshita T; Ohshima K; Seto M
    Cancer Res; 2014 Nov; 74(21):6129-38. PubMed ID: 25320005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
    Ohshima K
    Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation Analysis for TP53 in Chronic-Type Adult T-Cell Leukemia/Lymphoma.
    Yoshida N; Imaizumi Y; Utsunomiya A; Miyoshi H; Arakawa F; Tsukasaki K; Ohshima K; Seto M
    J Clin Exp Hematop; 2015; 55(1):13-6. PubMed ID: 26106001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia.
    Nosaka K; Maeda M; Tamiya S; Sakai T; Mitsuya H; Matsuoka M
    Cancer Res; 2000 Feb; 60(4):1043-8. PubMed ID: 10706122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL).
    Hatta Y; Koeffler HP
    Leukemia; 2002 Jun; 16(6):1069-85. PubMed ID: 12040438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma.
    Kataoka K; Iwanaga M; Yasunaga JI; Nagata Y; Kitanaka A; Kameda T; Yoshimitsu M; Shiraishi Y; Sato-Otsubo A; Sanada M; Chiba K; Tanaka H; Ochi Y; Aoki K; Suzuki H; Shiozawa Y; Yoshizato T; Sato Y; Yoshida K; Nosaka K; Hishizawa M; Itonaga H; Imaizumi Y; Munakata W; Shide K; Kubuki Y; Hidaka T; Nakamaki T; Ishiyama K; Miyawaki S; Ishii R; Nureki O; Tobinai K; Miyazaki Y; Takaori-Kondo A; Shibata T; Miyano S; Ishitsuka K; Utsunomiya A; Shimoda K; Matsuoka M; Watanabe T; Ogawa S
    Blood; 2018 Jan; 131(2):215-225. PubMed ID: 29084771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of multidrug resistance protein in adult T-cell leukemia.
    Ohno N; Tani A; Chen ZS; Uozumi K; Hanada S; Akiba S; Ren XQ; Furukawa T; Sumizawa T; Arima T; Akiyama SI
    Clin Cancer Res; 2001 Oct; 7(10):3120-6. PubMed ID: 11595704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter methylation of the bone morphogenetic protein-6 gene in association with adult T-cell leukemia.
    Taniguchi A; Nemoto Y; Yokoyama A; Kotani N; Imai S; Shuin T; Daibata M
    Int J Cancer; 2008 Oct; 123(8):1824-31. PubMed ID: 18688853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia.
    Omura-Minamisawa M; Diccianni MB; Batova A; Chang RC; Bridgeman LJ; Yu J; Pullen J; Bowman WP; Yu AL
    Clin Cancer Res; 2000 Apr; 6(4):1219-28. PubMed ID: 10778944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genomic analysis of adult T-cell leukemia.
    Choi YL; Tsukasaki K; O'Neill MC; Yamada Y; Onimaru Y; Matsumoto K; Ohashi J; Yamashita Y; Tsutsumi S; Kaneda R; Takada S; Aburatani H; Kamihira S; Nakamura T; Tomonaga M; Mano H
    Oncogene; 2007 Feb; 26(8):1245-55. PubMed ID: 16909099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adult T cell leukemia-lymphoma (ATL)].
    Tsukasaki K
    Nihon Rinsho; 2014 Mar; 72(3):531-7. PubMed ID: 24724415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of microRNA-145 down-regulation in adult T-cell leukemia/lymphoma.
    Xia H; Yamada S; Aoyama M; Sato F; Masaki A; Ge Y; Ri M; Ishida T; Ueda R; Utsunomiya A; Asai K; Inagaki H
    Hum Pathol; 2014 Jun; 45(6):1192-8. PubMed ID: 24745613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serum neuron-specific enolase in patients with adult T-cell leukemia.
    Fujiwara H; Arima N; Ohtsubo H; Matsumoto T; Kukita T; Kawada H; Imaizumi R; Ozaki A; Matsushita K; Tei C
    Am J Hematol; 2002 Oct; 71(2):80-4. PubMed ID: 12353304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of interleukin 2-toxin toward lymphocytes from patients with adult T-cell leukemia.
    Kiyokawa T; Shirono K; Hattori T; Nishimura H; Yamaguchi K; Nichols JC; Strom TB; Murphy JR; Takatsuki K
    Cancer Res; 1989 Jul; 49(14):4042-6. PubMed ID: 2786749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course.
    Tsukasaki K; Krebs J; Nagai K; Tomonaga M; Koeffler HP; Bartram CR; Jauch A
    Blood; 2001 Jun; 97(12):3875-81. PubMed ID: 11389029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features at transformation in adult T-cell leukemia-lymphoma with smoldering and chronic types.
    Taniguchi H; Imaizumi Y; Takasaki Y; Nakashima J; Kato T; Itonaga H; Sato S; Sawayama Y; Ando K; Hasegawa H; Hata T; Moriuchi Y; Tsukasaki K; Miyazaki Y
    Int J Hematol; 2019 Apr; 109(4):402-408. PubMed ID: 30680667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum dehydroepiandrosterone and DHEA-sulfate in patients with adult T-cell leukemia and human T-lymphotropic virus type I carriers.
    Uozumi K; Uematsu T; Otsuka M; Nakano S; Takatsuka Y; Iwahashi M; Hanada S; Arima T
    Am J Hematol; 1996 Nov; 53(3):165-8. PubMed ID: 8895686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and regulation of interleukin-4 receptor in adult T-cell leukemia cells.
    Mori N; Shirakawa F; Murakami S; Oda S; Eto S
    Eur J Haematol; 1996 Apr; 56(4):241-7. PubMed ID: 8641393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDKN2 (MTS1/p16INK4A) gene alterations in adult T-cell leukemia/lymphoma.
    Uchida T; Kinoshita T; Murate T; Saito H; Hotta T
    Leuk Lymphoma; 1998 Mar; 29(1-2):27-35. PubMed ID: 9638973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability.
    Pise-Masison CA; Radonovich M; Dohoney K; Morris JC; O'Mahony D; Lee MJ; Trepel J; Waldmann TA; Janik JE; Brady JN
    Blood; 2009 Apr; 113(17):4016-26. PubMed ID: 19131553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.